Cargando…
Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language sampling
BACKGROUND: The purpose of this study was to evaluate expressive language sampling (ELS) as a procedure for generating spoken language outcome measures for treatment research in Down syndrome (DS). We addressed (a) feasibility, (b) practice effects across two short-term administrations, (c) test-ret...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028777/ https://www.ncbi.nlm.nih.gov/pubmed/33827417 http://dx.doi.org/10.1186/s11689-021-09361-6 |
_version_ | 1783676004702617600 |
---|---|
author | Thurman, Angela John Edgin, Jamie O. Sherman, Stephanie L. Sterling, Audra McDuffie, Andrea Berry-Kravis, Elizabeth Hamilton, Debra Abbeduto, Leonard |
author_facet | Thurman, Angela John Edgin, Jamie O. Sherman, Stephanie L. Sterling, Audra McDuffie, Andrea Berry-Kravis, Elizabeth Hamilton, Debra Abbeduto, Leonard |
author_sort | Thurman, Angela John |
collection | PubMed |
description | BACKGROUND: The purpose of this study was to evaluate expressive language sampling (ELS) as a procedure for generating spoken language outcome measures for treatment research in Down syndrome (DS). We addressed (a) feasibility, (b) practice effects across two short-term administrations, (c) test-retest reliability across two short-term administrations, (d) convergent and discriminant construct validity, and (e) considered comparisons across the conversation and narration contexts. METHOD: Participants were 107 individuals with DS between 6 and 23 years of age who presented with intellectual disability (IQ < 70). The utility of ELS procedures designed to collect samples of spoken language in conversation and narration were evaluated separately. Variables of talkativeness, vocabulary, syntax, utterance planning, and articulation quality, derived from transcripts segmented into C-units (i.e., an independent clause and its modifiers), were considered. A 4-week interval was used to assess practice effects and test-retest reliability. Standardized direct assessments and informant report measures were collected to evaluate construct validity of the ELS variables. RESULTS: Low rates of noncompliance were observed; youth who were under 12 years of age, had phrase-level speech or less, and had a 4-year-old developmental level or less were at particular risk for experiencing difficulty completing the ELS procedures. Minimal practice effects and strong test-retest reliability across the 4-week test-retest interval was observed. The vocabulary, syntax, and speech intelligibility variables demonstrated strong convergent and discriminant validity. Although significant correlations were found between the variables derived from both the conversation and narration contexts, some differences were noted. CONCLUSION: The ELS procedures considered were feasible and yielded variables with adequate psychometric properties for most individuals with DS between 6 and 23 years old. That said, studies of outcome measures appropriate for individuals with DS with more limited spoken language skills are needed. Context differences were observed in ELS variables suggest that comprehensive evaluation of expressive language is likely best obtained when utilizing both contexts. |
format | Online Article Text |
id | pubmed-8028777 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80287772021-04-08 Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language sampling Thurman, Angela John Edgin, Jamie O. Sherman, Stephanie L. Sterling, Audra McDuffie, Andrea Berry-Kravis, Elizabeth Hamilton, Debra Abbeduto, Leonard J Neurodev Disord Research BACKGROUND: The purpose of this study was to evaluate expressive language sampling (ELS) as a procedure for generating spoken language outcome measures for treatment research in Down syndrome (DS). We addressed (a) feasibility, (b) practice effects across two short-term administrations, (c) test-retest reliability across two short-term administrations, (d) convergent and discriminant construct validity, and (e) considered comparisons across the conversation and narration contexts. METHOD: Participants were 107 individuals with DS between 6 and 23 years of age who presented with intellectual disability (IQ < 70). The utility of ELS procedures designed to collect samples of spoken language in conversation and narration were evaluated separately. Variables of talkativeness, vocabulary, syntax, utterance planning, and articulation quality, derived from transcripts segmented into C-units (i.e., an independent clause and its modifiers), were considered. A 4-week interval was used to assess practice effects and test-retest reliability. Standardized direct assessments and informant report measures were collected to evaluate construct validity of the ELS variables. RESULTS: Low rates of noncompliance were observed; youth who were under 12 years of age, had phrase-level speech or less, and had a 4-year-old developmental level or less were at particular risk for experiencing difficulty completing the ELS procedures. Minimal practice effects and strong test-retest reliability across the 4-week test-retest interval was observed. The vocabulary, syntax, and speech intelligibility variables demonstrated strong convergent and discriminant validity. Although significant correlations were found between the variables derived from both the conversation and narration contexts, some differences were noted. CONCLUSION: The ELS procedures considered were feasible and yielded variables with adequate psychometric properties for most individuals with DS between 6 and 23 years old. That said, studies of outcome measures appropriate for individuals with DS with more limited spoken language skills are needed. Context differences were observed in ELS variables suggest that comprehensive evaluation of expressive language is likely best obtained when utilizing both contexts. BioMed Central 2021-04-08 /pmc/articles/PMC8028777/ /pubmed/33827417 http://dx.doi.org/10.1186/s11689-021-09361-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Thurman, Angela John Edgin, Jamie O. Sherman, Stephanie L. Sterling, Audra McDuffie, Andrea Berry-Kravis, Elizabeth Hamilton, Debra Abbeduto, Leonard Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language sampling |
title | Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language sampling |
title_full | Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language sampling |
title_fullStr | Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language sampling |
title_full_unstemmed | Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language sampling |
title_short | Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language sampling |
title_sort | spoken language outcome measures for treatment studies in down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language sampling |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028777/ https://www.ncbi.nlm.nih.gov/pubmed/33827417 http://dx.doi.org/10.1186/s11689-021-09361-6 |
work_keys_str_mv | AT thurmanangelajohn spokenlanguageoutcomemeasuresfortreatmentstudiesindownsyndromefeasibilitypracticeeffectstestretestreliabilityandconstructvalidityofvariablesgeneratedfromexpressivelanguagesampling AT edginjamieo spokenlanguageoutcomemeasuresfortreatmentstudiesindownsyndromefeasibilitypracticeeffectstestretestreliabilityandconstructvalidityofvariablesgeneratedfromexpressivelanguagesampling AT shermanstephaniel spokenlanguageoutcomemeasuresfortreatmentstudiesindownsyndromefeasibilitypracticeeffectstestretestreliabilityandconstructvalidityofvariablesgeneratedfromexpressivelanguagesampling AT sterlingaudra spokenlanguageoutcomemeasuresfortreatmentstudiesindownsyndromefeasibilitypracticeeffectstestretestreliabilityandconstructvalidityofvariablesgeneratedfromexpressivelanguagesampling AT mcduffieandrea spokenlanguageoutcomemeasuresfortreatmentstudiesindownsyndromefeasibilitypracticeeffectstestretestreliabilityandconstructvalidityofvariablesgeneratedfromexpressivelanguagesampling AT berrykraviselizabeth spokenlanguageoutcomemeasuresfortreatmentstudiesindownsyndromefeasibilitypracticeeffectstestretestreliabilityandconstructvalidityofvariablesgeneratedfromexpressivelanguagesampling AT hamiltondebra spokenlanguageoutcomemeasuresfortreatmentstudiesindownsyndromefeasibilitypracticeeffectstestretestreliabilityandconstructvalidityofvariablesgeneratedfromexpressivelanguagesampling AT abbedutoleonard spokenlanguageoutcomemeasuresfortreatmentstudiesindownsyndromefeasibilitypracticeeffectstestretestreliabilityandconstructvalidityofvariablesgeneratedfromexpressivelanguagesampling |